Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 May;33(5):1363–1365. doi: 10.1128/jcm.33.5.1363-1365.1995

Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.

A L Bruu 1, S A Nordbø 1
PMCID: PMC228166  PMID: 7615755

Abstract

The following commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19 were evaluated: Ideia Parvovirus B19-IgM, MRL Diagnostics Human Parvovirus B19 IgM ELISA, Parvoscan-B19, and Biotrin Parvo B19 IgM EIA and IF. A total of 203 serum specimens from patients who probably have current B19 infections or have other viral infections and sera with rheumatoid factor were investigated. Between 75 and 79 of 102 serum samples from patients thought to have current B19 infections yielded positive results with the different tests. Ideia had the highest specificity (94.8%), while Parvoscan showed a specificity of only 70.1%. Our evaluation results show that Ideia, MRL, and Biotrin EIA and IF can be recommended for diagnostic purposes.

Full Text

The Full Text of this article is available as a PDF (144.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. J., Pattison J. R. The human parvovirus. Brief review. Arch Virol. 1984;82(3-4):137–148. doi: 10.1007/BF01311158. [DOI] [PubMed] [Google Scholar]
  2. Brown C. S., Salimans M. M., Noteborn M. H., Weiland H. T. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res. 1990 Mar;15(3):197–211. doi: 10.1016/0168-1702(90)90028-a. [DOI] [PubMed] [Google Scholar]
  3. Brown C. S., van Bussel M. J., Wassenaar A. L., van Elsacker-Niele A. M., Weiland H. T., Salimans M. M. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Methods. 1990 Jul;29(1):53–62. doi: 10.1016/0166-0934(90)90007-3. [DOI] [PubMed] [Google Scholar]
  4. Cohen B. J., Mortimer P. P., Pereira M. S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) 1983 Aug;91(1):113–130. doi: 10.1017/s0022172400060095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fridell E., Cohen B. J., Wahren B. Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19. J Clin Microbiol. 1991 Jul;29(7):1376–1381. doi: 10.1128/jcm.29.7.1376-1381.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fridell E., Trojnar J., Wahren B. A new peptide for human parvovirus B19 antibody detection. Scand J Infect Dis. 1989;21(6):597–603. doi: 10.3109/00365548909021686. [DOI] [PubMed] [Google Scholar]
  7. Koch W. C., Massey G., Russell C. E., Adler S. P. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr. 1990 Mar;116(3):355–359. doi: 10.1016/s0022-3476(05)82820-3. [DOI] [PubMed] [Google Scholar]
  8. Kurtz J. B., Anderson M. J. Cross-reactions in rubella and parvovirus specific IgM tests. Lancet. 1985 Dec 14;2(8468):1356–1356. doi: 10.1016/s0140-6736(85)92647-9. [DOI] [PubMed] [Google Scholar]
  9. Neild G., Anderson M., Hawes S., Colvin B. T. Parvovirus infection after renal transplant. Lancet. 1986 Nov 22;2(8517):1226–1227. doi: 10.1016/s0140-6736(86)92245-2. [DOI] [PubMed] [Google Scholar]
  10. Patou G., Pillay D., Myint S., Pattison J. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol. 1993 Mar;31(3):540–546. doi: 10.1128/jcm.31.3.540-546.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ. 1990 May 5;300(6733):1166–1170. doi: 10.1136/bmj.300.6733.1166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schwarz T. F., Roggendorf M., Deinhardt F. Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods. 1988 Jun;20(2):155–168. doi: 10.1016/0166-0934(88)90149-8. [DOI] [PubMed] [Google Scholar]
  13. WAGER O. On the factor producing agglutination of sensitized red cells and its relation to the agglutination of hemolytic streptococci in rheumatoid arthritis sera. Ann Med Exp Biol Fenn. 1950;28(8):1–72. [PubMed] [Google Scholar]
  14. WINBLAD S. Studies in laboratory estimation of rheumatoid arthritis serum factor. 3. Slide agglutination methods with and without sensitizing gamma globulin. Acta Pathol Microbiol Scand. 1960;49:523–528. [PubMed] [Google Scholar]
  15. Ware R. Human parvovirus infection. J Pediatr. 1989 Mar;114(3):343–348. doi: 10.1016/s0022-3476(89)80549-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES